Clinical Trial Update: Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.

View source ↗

Summary

This clinical trial investigates genetic markers that predict susceptibility to chemotherapy-induced ovarian damage in cancer patients undergoing ovarian biopsy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hodgkin Lymphoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Breast Cancer, Hodgkin Lymphoma | Status: RECRUITING